Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

We hypothesized that sirolimus, an mTOR inhibitor, may be effective in patients with autoimmune lymphoproliferative syndrome (ALPS) and treated patients who were intolerant to or failed other therapies. Four patients were treated for autoimmune cytopenias; all had a rapid complete or near complete r...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Teachey, David T., Greiner, Robert, Seif, Alix, Attiyeh, Edward, Bleesing, Jack, Choi, John, Manno, Catherine, Rappaport, Eric, Schwabe, Dirk, Sheen, Cecilia, Sullivan, Kathleen E., Zhuang, Hongming, Wechsler, Daniel S., Grupp, Stephan A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819393/
https://ncbi.nlm.nih.gov/pubmed/19208097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07595.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы